Exact Mass: 758.5848937999999

Exact Mass Matches: 758.5848937999999

Found 500 metabolites which its exact mass value is equals to given mass value 758.5848937999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PA(16:0/24:1(15Z))

[(2R)-3-(hexadecanoyloxy)-2-[(15Z)-tetracos-15-enoyloxy]propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(16:0/24:1(15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(16:1(9Z)/24:0)

[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(tetracosanoyloxy)propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(16:1(9Z)/24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:1(9Z)/24:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(18:0/22:1(13Z))

[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(18:0/22:1(13Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:0/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of erucic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(18:1(11Z)/22:0)

[(2R)-2-(docosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(18:1(11Z)/22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(11Z)/22:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of behenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(18:1(9Z)/22:0)

[(2R)-2-(docosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(18:1(9Z)/22:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(9Z)/22:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of behenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(20:0/20:1(11Z))

[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(icosanoyloxy)propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(20:0/20:1(11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:0/20:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(20:1(11Z)/20:0)

[(2R)-3-[(11Z)-icos-11-enoyloxy]-2-(icosanoyloxy)propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(20:1(11Z)/20:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:1(11Z)/20:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(22:0/18:1(11Z))

[(2R)-3-(docosanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(22:0/18:1(11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:0/18:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position and one chain of cis-vaccenic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(22:1(13Z)/18:0)

[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(octadecanoyloxy)propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(22:1(13Z)/18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:1(13Z)/18:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of stearic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(24:0/16:1(9Z))

[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(tetracosanoyloxy)propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(24:0/16:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:0/16:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(24:1(15Z)/16:0)

[(2R)-2-(hexadecanoyloxy)-3-[(15Z)-tetracos-15-enoyloxy]propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(24:1(15Z)/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:1(15Z)/16:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(22:0/18:1(9Z))

[(2R)-3-(docosanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propoxy]phosphonic acid

C43H83O8P (758.5825248)

PA(22:0/18:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(22:0/18:1(9Z)), in particular, consists of one docosanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

SM(d18:2(4E,14Z)/18:1(12Z)-2OH(9,10))

(2-{[(2S,3R,4E,14Z)-2-[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enamido]-3-hydroxyoctadeca-4,14-dien-1-yl phosphono]oxy}ethyl)trimethylazanium

C41H79N2O8P (758.5573744000001)

SM(d18:2(4E,14Z)/18:1(12Z)-2OH(9,10)) is a type of oxidized sphingolipid found in animal cell membranes. It usually consists of phosphorylcholine and ceramide. SM(d18:2(4E,14Z)/18:1(12Z)-2OH(9,10)) consists of a sphingosine backbone and a 9,10-hydroxy-octadecenoyl chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.

SM(d19:0/18:1(12Z)-O(9S,10R))

(2-{[(2S,3R)-3-hydroxy-2-(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanamido)nonadecyl phosphono]oxy}ethyl)trimethylazanium

C42H83N2O7P (758.5937578)

SM(d19:0/18:1(12Z)-O(9S,10R)) is a type of oxidized sphingolipid found in animal cell membranes. It usually consists of phosphorylcholine and ceramide. SM(d19:0/18:1(12Z)-O(9S,10R)) consists of a sphingosine backbone and a 9,10-epoxy-octadecenoyl chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.

SM(d19:0/18:1(9Z)-O(12,13))

(2-{[(2S,3R)-3-hydroxy-2-[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enamido]nonadecyl phosphono]oxy}ethyl)trimethylazanium

C42H83N2O7P (758.5937578)

SM(d19:0/18:1(9Z)-O(12,13)) is a type of oxidized sphingolipid found in animal cell membranes. It usually consists of phosphorylcholine and ceramide. SM(d19:0/18:1(9Z)-O(12,13)) consists of a sphingosine backbone and a 12,13-epoxy-octadecenoyl chain. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SM has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition, it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2, an enzyme that breaks down sphingomyelin into ceramide, has been found to localize exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme sphingomyelinase, which causes the accumulation of sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase.

PE-Cer(d16:2(4E,6E)/24:0(2OH))

N-(2-hydroxy-tetracosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine

C42H83N2O7P (758.5937578)

PA(18:0/22:1(11Z))

1-octadecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(19:1(9Z)/21:0)

1-(9Z-nonadecenoyl)-2-heneicosanoyl-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(20:1(11Z)/20:0)

1-(11Z-eicosenoyl)-2-eicosanoyl-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(21:0/19:1(9Z))

1-heneicosanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(22:1(11Z)/18:0)

1-(11Z-docosenoyl)-2-octadecanoyl-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(22:0/18:1(9Z))

1-docosanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(20:0/20:1(11Z))

1-eicosanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(18:1(9Z)/22:0)

1-(9Z-octadecenoyl)-2-docosanoyl-glycero-3-phosphate

C43H83O8P (758.5825248)

PA(P-20:0/21:0)

1-(1Z-eicosenyl)-2-heneicosanoyl-glycero-3-phosphate

C44H87O7P (758.6189081999999)

PA 40:1

1-heneicosanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphate

C43H83O8P (758.5825248)

PA O-41:1

1-(1Z-eicosenyl)-2-heneicosanoyl-glycero-3-phosphate

C44H87O7P (758.6189081999999)

CerPE 40:2;O3

N-(2-hydroxy-tetracosanoyl)-4E,6E-hexadecasphingadienine-1-phosphoethanolamine

C42H83N2O7P (758.5937578)

14:0-Glc-Cholesterol

3-O-(6-O-tetradecanoyl-alpha-D-glucopyranosyl)-cholest-5-en-3beta-ol

C47H82O7 (758.6060222000001)

ST 29:1;O;Hex;FA 12:0

C47H82O7 (758.6060222000001)

2-[[(2R)-3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

D013501 - Surface-Active Agents > D054709 - Lecithins

2-[[(2R)-3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

SM(d19:0/18:1(12Z)-O(9S,10R))

C42H83N2O7P (758.5937578)

SM(d19:0/18:1(9Z)-O(12,13))

C42H83N2O7P (758.5937578)

SM(d18:2(4E,14Z)/18:1(12Z)-2OH(9,10))

C41H79N2O8P (758.5573744000001)

2-[[3-hexadecanoyloxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-octadec-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-2-hexadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[hydroxy-[(2R)-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[hydroxy-[(2R)-2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[hydroxy-[(2R)-3-[(Z)-icos-11-enoyl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[hydroxy-[(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-tetradecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-3-[(E)-hexadec-1-enoxy]-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-2-[(E)-hexadec-1-enoxy]-3-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-3-[(E)-hexadec-1-enoxy]-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

2-[[(2R)-2-[(E)-hexadec-1-enoxy]-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

1-stearoyl-2-palmitoyl-3-alpha-D-galactosyl-sn-glycerol

C43H82O10 (758.5907672000001)

L-alpha-1-palmitoyl-2-linoleyl-[1-(14)C]-phosphatidylcholine

C42H81NO8P+ (758.5699496)

cholesteryl 6-O-myristoyl-alpha-D-glucoside

C47H82O7 (758.6060222000001)

A cholesteryl glycoside in which cholesterol is linked glycosidically via its 3-hydroxy group to 6-O-myristoyl-alpha-D-glucose. Produced naturally by Helicobacter pylori, a bacteria that colonizes the stomach and which is associated with protection against asthma, it is also chemically synthesized as PI57.

2-[[3-[(Z)-hexadec-1-enoxy]-2-[(10E,12Z)-9-hydroxyoctadeca-10,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C42H81NO8P+ (758.5699496)

4-[3-[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]oxy-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C50H78O5 (758.5848937999999)

(1-hydroxy-3-nonanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenoate

C50H78O5 (758.5848937999999)

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoate

C50H78O5 (758.5848937999999)

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-triaconta-6,9,12,15,18,21,24,27-octaenoate

C50H78O5 (758.5848937999999)

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-5,8,11,14,17,20,23,26,29-nonaenoate